UPDATE 1-Roche MS drug Ocrevus approved by FDA after 3-month delay

March 28 (Reuters) - The U.S. Food and Drug Administration

(FDA) on Tuesday approved Roche Holding AG's multiple

sclerosis (MS) drug Ocrevus, putting the potential blockbuster

drug back on track after a delay by regulators over

manufacturing issues.

Read more